TransCode Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.About RNAZ
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. Its lead product candidate is TTX-MC138, an antisense inhibitor of an oncogenic microRNA.
RNAZ Key Statistics
Stock Snapshot
As of today, TransCode Therapeutics(RNAZ) shares are valued at $8.56. The company's market cap stands at 8.13M, with a P/E ratio of -0.18.
On 2026-07-13, TransCode Therapeutics(RNAZ) stock moved within a range of $7.94 to $9.12. With shares now at $8.56, the stock is trading +7.8% above its intraday low and -6.1% below the session's peak.
Trading volume for TransCode Therapeutics(RNAZ) stock has reached 24.83K, versus its average volume of 44.86K.
Over the past 52 weeks, TransCode Therapeutics(RNAZ) stock has traded between a high of $20.99 and a low of $3.82.
Over the past 52 weeks, TransCode Therapeutics(RNAZ) stock has traded between a high of $20.99 and a low of $3.82.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.